FDA Sets Review Period for Impella Heart Device Patent
Published Date: 6/16/2025
Notice
Summary
The FDA has officially set the review period for the IMPELLA RP FLEX WITH SMART ASSIST medical device, helping the patent owner get extra time to protect their invention. This means the company can extend their patent, keeping competitors at bay a little longer. If you’re in the medical device world, watch for these timing updates—they could impact when new versions hit the market and affect innovation money flows.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in